Valneva shares are trading lower after the company commented on data published from the COV-Boost COVID-19 vaccine trial, saying it believes 'it is likely that the short interval between the second shot and booster shot could have adversely impacted the results for VLA2001.'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!